Debate over the growth picture continues with global expenditure data through September showing resilience but the labor market a key area of weakness. Whether wealth effects will cushion the coming purchasing power squeeze in the US is unclear. But we maintain that there is a tension in risk markets pricing both resilience and a Fed that returns rates to neutral, with inflation looking sticky absent a more material soft patch in growth.

Speakers:

Bruce Kasman

Joseph Lupton

This communication is provided for information purposes only. Institutional clients please visit www.jpmm.com/research/disclosures for important disclosures. © 2025 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party.

Dexmedetomidine ICU Clinical Pearls

Pharmacy to Dose: The Critical Care Podcast

When should dexmedetomidine be initiated for AWS?

The AI-powered Podcast Player